Allison Dauner as an expert immunologist supporting the Translational Biomarkers group in Sanofi’s mRNA Center of Excellence, utilizes her many years of experience in infectious diseases and vaccine development to drive the discovery of clinical biomarkers which will enable rapid identification of life-saving vaccines. In her current role, She leads a team developing clinical assays as well as supporting Phase 1 clinical trial translational strategy and assay selection to ensure the accurate assessment of meaningful exploratory endpoints. Her post-doctoral fellowships at the Centers for Disease Control and Prevention and the Department of Defense working on practical solutions to diseases affecting public health and military readiness fueled her passion for applied research, with improving the quality of people’s lives as one of her guiding principles.